← Back to Search

Shine for HIV/AIDS

Waitlist Available
Led By Samantha Leaf, Ph.D.
Research Sponsored by ISA Associates, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
able to speak/understand English
African American/Black
Screening 3 weeks
Treatment Varies
Follow Up baseline and month 6
Awards & highlights

Study Summary

This trial will test if the mobile HIV behavioral intervention for African American transgender women (Shine) is more effective than the mobile HIV education for transgender women in reducing the composite HIV transmission risk.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Percentage of Participants With HIV Transmission Risk at Month 6
Secondary outcome measures
Change in ART Adherence at Month 6
Change in Barriers to ART Use at Month 6
Change in Barriers to Condom Use at Month 6
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Shine InterventionExperimental Treatment1 Intervention
Experimental group participants will have access to the mobile Shine intervention.
Group II: Control VideosActive Control1 Intervention
Control condition participants will be texted an embedded link to a series of videos developed by the Centers for Disease Control. These videos describe healthy HIV-related behaviors for trans women of any status (e.g., recommended testing frequencies, PrEP, ART, condoms), includes videos of trans women describing their experiences with HIV. All control participants will have access to Shine at the end of the research study (i.e., approximately six months after recruitment).
First Studied
Drug Approval Stage
How many patients have taken this drug

Find a Location

Who is running the clinical trial?

ISA Associates, Inc.Lead Sponsor
4 Previous Clinical Trials
811 Total Patients Enrolled
Samantha Leaf, Ph.D.Principal InvestigatorISA Associates

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are actively contributing to the data collection for this research?

"Affirmative. Clinicaltrials.gov data attests that this research trial, which was posted in November 2021, is currently recruiting participants. 215 individuals need to be enrolled from 1 medical centre for the completion of this clinical investigation."

Answered by AI

What is the current status of this experiment with regard to participant enrollment?

"Affirmative. Records from clinicaltrials.gov attests to the fact that this medical experiment, which was posted on November 16th 2021, is still recruiting participants. There are currently 215 patients needed for this single-site study."

Answered by AI
~11 spots leftby Apr 2025